Results 41 to 50 of about 12,382 (173)
Complement blockade in the management of antineutrophil cytoplasmic antibodyassociated vasculitis
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) are characterized by the presence of ANCA, particularly those directed against proteinase 3 (PR3) or myeloperoxidase (MPO).
José Salvador GarcÃa-Morillo +2 more
doaj +1 more source
The effects of NETs on regeneration of various diabetic tissues, and strategies targeting NETs for diabetes tissue regeneration. In the diabetic environment, NETs undergo complex metabolic and immune reprogramming, leading to dynamic changes in antibacterial and proinflammatory functions, and affecting regeneration of multiple systemic tissues.
Xinyi Jiang +6 more
wiley +1 more source
Antineutrophil cytoplasmic antibodies (ANCA) are autoantibodies directed at lysosomal constituens of leucocytes, with two major immunufluoresence stainig patterns: cytoplasmic (c-ANCA), and perinuclear (p-ANCA).
Ali Rıza Odabaş +2 more
doaj
Antineutrophil cytoplasmic antibodies (ANCAs) are associated with small vessel vasculitis but their prevalence is not rare in other immune diseases.
Joana Eugénio Santos +6 more
doaj +2 more sources
Levels of anti‐integrin αvβ6 antibodies were significantly higher in pediatric‐onset primary sclerosing cholangitis (PSC) than in autoimmune hepatitis (AIH) and may reflect disease activity. These antibodies may serve as a novel biomarker for distinguishing PSC from AIH and for monitoring disease progression.
Yukako Maeda +17 more
wiley +1 more source
One of the most common causes of rapidly progressive glomerulonephritis (GN) is the so-called pauci-immune crescentic GN that is characterized by no luminescence in kidney tissue samples during immunofluorescence microscopy and by the hyperproduction
T. V. Beketova +5 more
doaj +1 more source
Antineutrophil cytoplasmic antibody in uveitis and scleritis [PDF]
AbstractWe report a case where the detection of antineutrophil cytoplasmic antibody (ANCA) at the time of diagnosis of a case of sclero‐uveitis predicted the later development of systemic features and prompted an early and definitive diagnosis of systemic vasculitis.
R A, Mills +3 more
openaire +2 more sources
Abstract Background and aims Real‐world evaluation of clinical characteristics and treatment profile of patients with idiopathic pulmonary fibrosis (IPF) is needed to establish areas for improvement according to evidence‐based recommendations. This study evaluated the clinical characteristics and treatment profile of patients with IPF from the ...
Michelle Chee +31 more
wiley +1 more source
Overlap syndrome of systemic sclerosis with antineutrophil cytoplasmic antibody-associated vasculitis according to 2022 ACR/EULAR criteria [PDF]
Background/Aims This study applied the 2022 American College of Rheumatology (ACR)/European Alliance of Associations for Rheumatology (EULAR) criteria for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) to patients with systemic ...
Jang Woo Ha +5 more
doaj +1 more source
Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosis
Background Up to 12% of patients with systemic sclerosis (SSc) have anti-neutrophil cytoplasmic antibodies (ANCA). However, the majority of these patients do not manifest ANCA-associated vasculitis (AAV) and the significance of ANCA in these patients is ...
Jayne Moxey +12 more
doaj +1 more source

